Evusheld

UK approves AstraZeneca’s antibody-based COVID-19 treatment

UK approves AstraZeneca’s antibody-based COVID-19 treatment

  • Evusheld was already authorized in the US to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines
By Reuters ·